Lannett Co., Inc.

( )
LCI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
LLYEli Lilly & Co. -0.18%370.421.1%$1216.50m
JNJJohnson & Johnson 0.43%178.760.7%$1165.03m
MRKMerck & Co., Inc. -0.26%109.830.7%$1038.47m
PFEPfizer Inc. 2.02%51.140.9%$1008.93m
ABBVAbbVie, Inc. 0.25%161.581.9%$870.39m
BMYBristol-Myers Squibb Co. 0.74%80.871.1%$766.18m
AZNAstraZeneca Plc 0.54%68.341.0%$362.77m
HZNPHorizon Therapeutics Plc 0.59%100.885.4%$307.91m
IDXXIDEXX Laboratories, Inc. 3.12%439.173.9%$238.83m
CTLTCatalent, Inc. 4.21%52.241.9%$232.12m
GSKGSK Plc 1.29%35.040.3%$196.56m
NVSNovartis AG 0.28%89.810.2%$189.49m
NVONovo Nordisk A/S 1.22%126.130.1%$174.86m
ALNYAlnylam Pharmaceuticals, Inc. -0.15%220.258.0%$161.88m
RGENRepligen Corp. 5.22%188.176.7%$140.92m

Company Profile

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.